Photodynamic therapy of cholangiocarcinoma cancer.
Prognosis of nonresectable cholangiocarcinoma is not good, and in Bismuth type III and IV tumors relief of jaundice is seldom achieved, despite successful endoprosthesis insertion. Additional photodynamic therapy seems to be a promising new approach to these tumors. First pilot studies show relief of jaundice, mainly because of opening of the intrahepatic ducts and improvements in quality of life indices. Survival time seems to be long; however, randomized studies are necessary to confirm these results.
Ortner
M A
MA
Endoscopy Unit, Department of Gastroenterology/Hepatology/Endocrinology, Humboldt University Charite CCN, Berlin, Germany. marianne.ortner@charite.de
D001650:Bile Duct Neoplasms / Q000188:drug therapy* / Q000473:pathology; D001653:Bile Ducts, Intrahepatic; D018281:Cholangiocarcinoma / Q000188:drug therapy* / Q000473:pathology; D002986:Clinical Trials as Topic; D004333:Drug Administration Routes; D006801:Humans; D053685:Laser Therapy; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D011379:Prognosis
D017319:Photosensitizing Agents